The development of cancer is usually accompanied by inflammation and cancer development and metastasis can be inhibited by treating or controlling inflammation and blocking the production of related factors (e.g., TNF-α, IL-6, IL-17, etc.)(Landskron et al., 2014). Here, IL17A is linked to cancer.